India's pharmaceutical sector has entered the second half of 2026 on a strong footing, with exports rising 6.6% year-on-year and the Nifty Pharma index hitting an all-time high in early…
India's reputation as the "Pharmacy of the World" rests on its ability to produce high-quality generic medicines at affordable prices. However, the past few years have exposed serious quality challenges…
India's pharmaceutical sector continues to strengthen its global position with a series of positive developments in mid-2026. From extending its lead over China in US FDA drug master filings to…
India's Central Drugs Standard Control Organization (CDSCO) is the national regulatory authority responsible for approving, monitoring, and regulating pharmaceutical products in the country. For international buyers seeking high-quality generic medicines…